Dignify Therapeutics, LLC
Durham, NC Doing business as Dignify Therapeutics LLC
- UEI
- LG53EH7JZLK4
- CAGE
- 6XWQ2
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- SAM.gov registration date
- Physical address
- 2 Davis Dr, Durham, NC 27703, USA
- Website
- dignifytherapeutics.com
- Founded
- 2013
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Therapy for fecal incontinence and fecalurgency - fecal incontinence and fecal urgency (FI/FU) are extremely… | National Institute of Diabetes and Digestive and Kidney Diseases | $782,916 | |
| Novel treatment for urinary incontinence and overactive bladder symptoms in the elderly - abstract urinary… | National Institute on Aging | $499,892 | |
| Intrarectal mechanoreceptor sensitization to induce defecation after spinal injury | Defense Health Agency | $1,881,069 | |
| Preclinical and early clinical development of a novel drug for on-demand voiding - abstract spinal cord injury, multiple… | National Institute of Neurological Disorders and Stroke | $7,975,004 | |
| Neurokinin-2 receptor-induced micturition and defecation in aged diabetic rats | National Institute of Diabetes and Digestive and Kidney Diseases | $244,124 |
About Dignify Therapeutics, LLC
Dignify Therapeutics, LLC is a for-profit biotechnology company registered in SAM.gov since 2013, specializing in developing neurological therapies targeting sacral spinal cord neurons and addressing conditions related to bladder, bowel, and sexual function. The company focuses on creating novel drug formulations and therapeutic approaches for patients with neurological conditions, aging-related complications, and specific medical challenges involving continence and functional control.
Through federal grant awards from agencies like the National Institute of Neurological Disorders and Stroke, National Institute on Aging, National Institute of Diabetes and Digestive and Kidney Diseases, and the Defense Health Agency, Dignify Therapeutics has pursued research and development of innovative treatments for urinary and fecal incontinence, overactive bladder symptoms, and neurological dysfunction. The company's grant-funded projects have included developing drug candidates like DTI-117 for on-demand voiding, creating intravesical and intrarectal drug therapies to block pain-sensing neurons, and researching mechanisms to restore voluntary control of bodily functions for patients with spinal cord injuries, multiple sclerosis, Parkinson's disease, and age-related conditions. Notable collaborations include a sub-grant with Augusta University Research Institute, Inc., and the company has secured multiple project grants totaling several million dollars to advance preclinical research, formulation development, and potential clinical trials for its therapeutic pipeline.
Quick answers
What is Dignify Therapeutics, LLC's UEI?
Dignify Therapeutics, LLC's Unique Entity ID (UEI) in SAM.gov is LG53EH7JZLK4.
What is Dignify Therapeutics, LLC's CAGE code?
Dignify Therapeutics, LLC's CAGE code is 6XWQ2.
Where is Dignify Therapeutics, LLC located?
Dignify Therapeutics, LLC's physical address in SAM.gov is 2 Davis Dr, Durham, NC 27703, USA.
Is Dignify Therapeutics, LLC registered in SAM.gov?
Yes. Dignify Therapeutics, LLC's SAM.gov registration is active through November 13, 2026.
What is Dignify Therapeutics, LLC's most recent federal award?
Dignify Therapeutics, LLC's most recent federal grant award is Therapy for fecal incontinence and fecalurgency - fecal incontinence and fecal urgency (FI/FU) are extremely… (R43DK138600), from National Institute of Diabetes and Digestive and Kidney Diseases, on September 15, 2024.
On GovTribe
See Dignify Therapeutics, LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors